Stay updated on Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page

  1. Check
    11 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.6.3 to v3.6.4, indicating a minor maintenance update to the ClinicalTrials.gov record. No substantive study information appears to change.
    Difference
    0.0%
    Check dated 2026-07-25T11:39:55.000Z thumbnail image
  2. Check
    18 days ago
    No Change Detected
  3. Check
    25 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision bumped from v3.6.2 to v3.6.3, indicating a small update to the site’s revision metadata and backend; it does not alter the displayed study details or page structure.
    Difference
    0.0%
    Check dated 2026-07-04T03:52:45.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page revision was updated to v3.6.2, replacing v3.6.0, indicating a newer version of the study page content and metadata. This appears to be a minor technical update rather than a substantive change to study information.
    Difference
    0.0%
    Check dated 2026-06-26T19:48:22.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Recruitment status updated to not actively recruiting and enrollment updated to 70 participants. New navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the study timeline was updated to show primary completion on 2027-12-31 and study completion on 2030-12-31.
    Difference
    1%
    Check dated 2026-06-12T13:37:07.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, reflecting a minor update to the page metadata. The change represents an internal update to the ClinicalTrials.gov entry rather than a modification to the study content or results.
    Difference
    0.0%
    Check dated 2026-06-05T08:29:44.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4, indicating a minor update to the page's template or backend. No study content or user-facing information was changed.
    Difference
    0.0%
    Check dated 2026-05-15T02:23:33.000Z thumbnail image

Stay in the know with updates to Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page.